We’re thrilled to announce that we’re one of the recipients of the Pipeline Accelerator 2023-24 Award!
Created by Phenomics Australia and Therapeutic Innovation Australia (TIA) and enabled by the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS), this award aims to bridge the translational gap and accelerate clinical development of novel therapies.
Led by our Chief Technology Officer, Dr Iva Nikolic, our functional genomics and target discovery team will use these funds to develop cutting-edge methods for high-throughput compound screening in primary human immune cells.
We can’t wait to start working with the Victorian Centre for Functional Genomics on this project, and we’d like to thank Phenomics Australia and TIA for their support – this funding will help us achieve our goal of creating effective immunotherapies for solid tumors.